{
  "docId": "019de073-bfd4-723b-805d-c3152d3a00ff",
  "docSlug": "7df1d9bdbc08777b7243fabbc766ed39",
  "documentTitle": "Immatics | Results Presentation Deck | 25 slides",
  "authorId": "immatics",
  "authorName": "Immatics",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7860465,
  "pageNumber": 10,
  "pageCount": 25,
  "prevPage": 9,
  "nextPage": 11,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 16,
  "notes": "Data cut-off 06-Sept-2022. Footnotes define ORR and cORR criteria.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-bfd4-723b-805d-c3152d3a00ff/10",
  "deckHref": "/decks/019de073-bfd4-723b-805d-c3152d3a00ff",
  "deckJsonHref": "/decks/019de073-bfd4-723b-805d-c3152d3a00ff.json",
  "deckAnchorHref": "/decks/019de073-bfd4-723b-805d-c3152d3a00ff#slide-10",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.7,
        "x": 0.12,
        "y": 0.75
      },
      "kind": "list",
      "text": "Higher ORR and confirmed ORR observed at doses above 1 billion TCR-T cells (DL4, DL5)\nEarly trends towards higher ORR and confirmed ORR observed in Phase 1b vs. Phase 1a patients",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f3033e16-c487-4ce1-94a9-314520e7e1fa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.96,
        "x": 0.02,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "All patients received >1 x 10^9 total transduced viable CD8 T cells; ORR: Objective response rate (partial responses) according to RECIST 1.1 at first scan post infusion (~6 weeks); Confirmed ORR (cORR): Confirmed objective response rate (confirmed partial responses) according to RECIST 1.1 at second scan post infusion (~12 weeks); * 1 patient with SD at ~ 6-week scan with pending ~12-week scan considered as non-responder for cORR.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b46d9475-5acb-4d92-9bed-1426ca07e2e7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.76,
        "x": 0.12,
        "y": 0.3
      },
      "kind": "table",
      "text": "Table showing Patients Treated, ORR, and cORR for Phase 1a (All, DL4) and Phase 1b (DL4/DL5) cohorts.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7e6993a9-8bd2-44b5-a8df-134b8436f976",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.65,
        "x": 0.04,
        "y": 0.11
      },
      "kind": "title",
      "text": "Improved ORR and Confirmed ORR at Higher Dose and in Phase 1b Cohort A",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bc43877b-9d5b-4b8a-a852-651c166a4bad",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.45,
        "x": 0.04,
        "y": 0.06
      },
      "kind": "title",
      "text": "Frequency of Observed Objective Responses",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "10eabb30-2fc3-4721-b6bc-c1c1cd42ae44",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 17,
      "from": 9,
      "beatId": "3c0d3c19-4cb2-45ea-940b-4a17ae6aecd2",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "Slides 9-17 present the interim clinical data and results of ACTengine IMA203.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 15,
      "from": 6,
      "name": "Before After",
      "slug": "21-before-after",
      "bestFor": "Product demos, process improvements, ROI justification",
      "matchId": "f1808ddc-c99c-471d-823a-31b9839269d3",
      "evidence": "Slides 6 and 15 show the before and after comparison.",
      "position": 0,
      "objective": "Show improvement from Phase 1a to Phase 1b",
      "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta",
      "confidence": 0.7,
      "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}